Cargando…

Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway

BACKGROUND: Cancer cells have an imbalance in oxidation-reduction (redox) homeostasis. Understanding the precise mechanisms and the impact of the altered redox microenvironment on the immunologic reaction to tumors is limited. METHODS: We isolated exosomes from ovarian cancer cells through ultracent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiang, Wang, Shaomin, Mu, Wei, Barry, Jennifer, Han, Anna, Carpenter, Richard L., Jiang, Bing-Hua, Peiper, Stephen C., Mahoney, Mỹ G., Aplin, Andrew E., Ren, Hong, He, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793215/ https://www.ncbi.nlm.nih.gov/pubmed/35086548 http://dx.doi.org/10.1186/s13046-022-02244-1

Ejemplares similares

Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy
por: Wang, Bin, et al.
Publicado: (2020)

Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems
por: Su, Mei-Ju, et al.
Publicado: (2016)

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
por: Kamerkar, Sushrut, et al.
Publicado: (2022)

The Role of miR-155 in Antitumor Immunity
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity
por: Peng, Hao-Yun, et al.
Publicado: (2021)

Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression
por: Azambuja, Juliana H., et al.
Publicado: (2020)

Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
por: Cai, Hao, et al.
Publicado: (2021)

Metabolic Reprogramming, Autophagy, and Reactive Oxygen Species Are Necessary for Primordial Germ Cell Reprogramming into Pluripotency
por: Sainz de la Maza, D., et al.
Publicado: (2017)

Macrophage-derived exosomal miRNA-155 promotes tubular injury in ischemia-induced acute kidney injury
por: Zhang, Zhijian, et al.
Publicado: (2022)

Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species
por: Sestili, Piero, et al.
Publicado: (2015)

Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
por: Kotsafti, Andromachi, et al.
Publicado: (2020)

Roles of Reactive Oxygen Species in Cardiac Differentiation, Reprogramming, and Regenerative Therapies
por: Liang, Jialiang, et al.
Publicado: (2020)

Tissue-infiltrating macrophages mediate an exosome-based metabolic reprogramming upon DNA damage
por: Goulielmaki, Evi, et al.
Publicado: (2020)

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
por: Cooks, Tomer, et al.
Publicado: (2018)

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity
por: Kaul, Kirti, et al.
Publicado: (2021)

Exosomes Derived From Hypertrophic Cardiomyocytes Induce Inflammation in Macrophages via miR-155 Mediated MAPK Pathway
por: Yu, Hui, et al.
Publicado: (2021)

Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation
por: Wang, Piaopiao, et al.
Publicado: (2019)

Reactive Oxygen Species in Macrophages: Sources and Targets
por: Canton, Marcella, et al.
Publicado: (2021)

Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity
por: Rashida Gnanaprakasam, Josephin N., et al.
Publicado: (2018)

Antimicrobial mitochondrial reactive oxygen species induction by lung epithelial metabolic reprogramming
por: Wang, Yongxing, et al.
Publicado: (2023)

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
por: Bu, Xia, et al.
Publicado: (2021)

Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity
por: Qian, Husun, et al.
Publicado: (2022)

Macrophage reprogramming for therapy
por: Bart, Valentina M. T., et al.
Publicado: (2021)

Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming
por: Gyukity-Sebestyén, Edina, et al.
Publicado: (2019)

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
por: Richert, Iseulys, et al.
Publicado: (2023)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression
por: Niu, Lian-Jie, et al.
Publicado: (2021)

Reprogramming of PD-1(+) M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma
por: Han, Zhen, et al.
Publicado: (2023)

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage
por: Wu, Fengjiao, et al.
Publicado: (2022)

microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82
por: Song, Li, et al.
Publicado: (2022)

Testicular exosomes disturb the immunosuppressive phenotype of testicular macrophages mediated by miR-155-5p in uropathogenic Escherichia coli-induced orchitis
por: Xu, Jia, et al.
Publicado: (2022)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Impact of epigenetic reprogramming on antitumor immune responses in glioma
por: McClellan, Brandon L., et al.
Publicado: (2023)

Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155
por: Kim, Sinae, et al.
Publicado: (2021)

Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer
por: Qin, Huan, et al.
Publicado: (2023)

Control of the Inflammatory Macrophage Transcriptional Signature by miR-155
por: Jablonski, Kyle A., et al.
Publicado: (2016)

PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression
por: Jiang, Yongshuai, et al.
Publicado: (2021)

Bioenergetic reprogramming of articular chondrocytes by exposure to exogenous and endogenous reactive oxygen species and its role in the anabolic response to low oxygen
por: Heywood, H. K., et al.
Publicado: (2016)

Metabolic Reprograming in Macrophage Polarization
por: Galván-Peña, Silvia, et al.
Publicado: (2014)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_67i443012rql5nvgmrgnoalqvr